These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2620472)

  • 21. Malignant or accelerated hypertension in IgA nephropathy.
    Subías R; Botey A; Darnell A; Montoliu J; Revert L
    Clin Nephrol; 1987 Jan; 27(1):1-7. PubMed ID: 3815903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies.
    Jones DB
    Lab Invest; 1974 Oct; 31(4):303-13. PubMed ID: 4412080
    [No Abstract]   [Full Text] [Related]  

  • 23. Histopathological Association between Vascular Hypertensive Changes and Different Types of Glomerulopathies.
    Baki AH; Soliman Y; Seif EI
    Arab J Nephrol Transplant; 2014 Jan; 7(1):21-6. PubMed ID: 24702530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology of malignant nephrosclerosis with special reference to the difference between histologic manifestations of pure and exacerbated forms.
    Fujimoto T
    Tohoku J Exp Med; 1978 Jun; 125(2):135-53. PubMed ID: 694919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic role of angiotensin II and the NF-κB system in a model of malignant hypertensive nephrosclerosis.
    Ávila VF; Foresto-Neto O; Arias SCA; Faustino VD; Malheiros DMAC; Camara NOS; Zatz R; Fujihara CK
    Hypertens Res; 2019 Jun; 42(6):779-789. PubMed ID: 30809002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites.
    Tracy RE
    Semin Nephrol; 1996 Mar; 16(2):126-33. PubMed ID: 8668860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertensive nephrosclerosis.
    Hill GS
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):266-70. PubMed ID: 18408477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic hypertension and the kidney in black patients.
    Dustan HP; Curtis JJ; Luke RG; Rostand SG
    Am J Cardiol; 1987 Dec; 60(17):73I-77I. PubMed ID: 3687809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrosclerosis: update on a centenarian.
    Meyrier A
    Nephrol Dial Transplant; 2015 Nov; 30(11):1833-41. PubMed ID: 25488894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is 'nephrosclerosis'? lessons from the US, Japan, and Mexico.
    Tracy RE; Ishii T
    Nephrol Dial Transplant; 2000 Sep; 15(9):1357-66. PubMed ID: 10978391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume.
    Denic A; Mathew J; Nagineni VV; Thompson RH; Leibovich BC; Lerman LO; Lieske JC; Alexander MP; Augustine JJ; Kremers WK; Rule AD
    J Am Soc Nephrol; 2018 Jul; 29(7):1960-1969. PubMed ID: 29789431
    [No Abstract]   [Full Text] [Related]  

  • 33. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy.
    Hoy WE; Douglas-Denton RN; Hughson MD; Cass A; Johnson K; Bertram JF
    Kidney Int Suppl; 2003 Feb; (83):S31-7. PubMed ID: 12864872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Organic diseases and circulation. Development of renal lesions simulating renovascular hypertension in malignant nephrosclerosis].
    Fujimoto T
    Nihon Rinsho; 1981 Nov; 39(11):3596-601. PubMed ID: 7334643
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypertension in black South Africans--new perspectives on old material.
    Isaacson C; Milne FJ; van Niekerk I
    S Afr Med J; 1989 Oct; 76(7):323-4. PubMed ID: 2799577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic/secreting and apoptotic phenotypes in renal biopsy tissues from hypertensive nephrosclerosis patients.
    Kimura N; Yonemoto S; Machiguchi T; Li X; Kimura H; Yoshida H
    Hypertens Res; 2006 Aug; 29(8):573-80. PubMed ID: 17137212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histopathological findings in 3 cases of malignant nephrosclerosis as related to current problems of the syndrome].
    Bartolini G; Cecchi M; Ambrosi L
    Arch De Vecchi Anat Patol; 1974 Aug; 60(1):43-66. PubMed ID: 4470382
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis].
    Guo YS; Yuan WJ; Yu JP; Mei XB; Ye HY; Bian Q; Xu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):391-5. PubMed ID: 16776947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked proteinuria in hypertensive nephrosclerosis.
    Mujais SK; Emmanouel DS; Kasinath BS; Spargo BH
    Am J Nephrol; 1985; 5(3):190-5. PubMed ID: 3160240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal biopsy findings in presumed hypertensive nephrosclerosis.
    Freedman BI; Iskander SS; Buckalew VM; Burkart JM; Appel RG
    Am J Nephrol; 1994; 14(2):90-4. PubMed ID: 8080012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.